Literature DB >> 16930207

Glutamate-dopamine cotransmission and reward processing in addiction.

Christopher C Lapish1, Jeremy K Seamans, L Judson Chandler.   

Abstract

While Dale's principle of "one neuron, one neurotransmitter" has undergone revisions to incorporate evidence of the corelease of atypical neurotransmitters such as neuropeptides, the corelease of classical neurotransmitters has only recently been realized. Surprisingly, numerous studies now indicate that the corelease of neurotransmitters in the mammalian central nervous system is not an obscure and rare phenomenon but is widespread and involves most classical neurotransmitters systems. However, the suggestion that glutamate can be coreleased with dopamine (DA) has remained controversial. Furthermore, glutamate-DA cotransmission has not yet been seriously considered in the context of the neurocircuitry of addiction. If glutamate is in fact coreleased with DA as some evidence now suggests, this may have significant implications for advancing our understanding of the interactive role that these 2 neurotransmitters play in cognitive and reward processes. In this commentary, we review the evidence for and against glutamate as a cotransmitter and discuss the potential role of glutamate-DA corelease in addiction. In particular, we describe a recently proposed model in which coreleased glutamate transmits a temporally precise prediction error signal of reward described by Schultz et al., whereas the function of coreleased DA is to exert prolonged modulatory influences on neuronal activity. In addition, we suggest that as alcohol consumption transitions from recreational use to addiction, there is a corresponding transition in the reward valence signal from better than predicted to worse than predicted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930207     DOI: 10.1111/j.1530-0277.2006.00176.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  39 in total

Review 1.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

Review 2.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

3.  Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.

Authors:  Jocelyn M Richard; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

Review 4.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

Review 5.  Aberrant learning and memory in addiction.

Authors:  Mary M Torregrossa; Philip R Corlett; Jane R Taylor
Journal:  Neurobiol Learn Mem       Date:  2011-03-03       Impact factor: 2.877

6.  Inputs to the midbrain dopaminergic complex in the rat, with emphasis on extended amygdala-recipient sectors.

Authors:  Daniel S Zahm; Anita Y Cheng; Tristan J Lee; Comeron W Ghobadi; Zachary M Schwartz; Stefanie Geisler; Kenneth P Parsely; Clemens Gruber; Ruediger W Veh
Journal:  J Comp Neurol       Date:  2011-11-01       Impact factor: 3.215

Review 7.  Neurotransmitter corelease: mechanism and physiological role.

Authors:  Thomas S Hnasko; Robert H Edwards
Journal:  Annu Rev Physiol       Date:  2011-10-31       Impact factor: 19.318

8.  Riluzole and D-amphetamine interactions in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Thomas Kosten
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-05-18       Impact factor: 5.067

Review 9.  Metabolic hormones, dopamine circuits, and feeding.

Authors:  Nandakumar S Narayanan; Douglas J Guarnieri; Ralph J DiLeone
Journal:  Front Neuroendocrinol       Date:  2009-10-28       Impact factor: 8.606

10.  Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.

Authors:  Konstantin Voronin; Patrick Randall; Hugh Myrick; Raymond Anton
Journal:  Alcohol Clin Exp Res       Date:  2008-09-08       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.